Literature DB >> 6202231

Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis.

S Sato, R H Quarles, R O Brady, W W Tourtellotte.   

Abstract

Incubation of human myelin at neutral pH resulted in the proteolytic conversion of the myelin-associated glycoprotein to a lower molecular weight derivative (dMAG) and the degradation of basic protein. The formation of dMAG occurred much more rapidly than the degradation of basic protein. The formation of dMAG and the degradation of basic protein both occurred significantly more rapidly in myelin preparations purified from brains of patients with multiple sclerosis than in preparations from control brain. The results suggest that this neutral protease associated with myelin may function in the pathogenesis of demyelinating diseases such as multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202231     DOI: 10.1002/ana.410150310

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

Review 1.  Monoclonal antibodies to myelin-associated glycoprotein reveal antigenic structures and suggest pathogenic mechanisms.

Authors:  A J Steck; N Murray
Journal:  Springer Semin Immunopathol       Date:  1985

2.  The regional and subcellular distribution of calcium activated neutral proteinase (CANP) in the bovine central nervous system.

Authors:  A K Chakrabarti; N L Banik; J M Powers; E L Hogan
Journal:  Neurochem Res       Date:  1989-03       Impact factor: 3.996

3.  Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.

Authors:  Nicole Trager; Amena Smith; Gerald Wallace Iv; Mitsuyoshi Azuma; Jun Inoue; Craig Beeson; Azizul Haque; Naren L Banik
Journal:  J Neurochem       Date:  2014-02-12       Impact factor: 5.372

4.  A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain.

Authors:  D C Shields; K E Schaecher; T C Saido; N L Banik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis.

Authors:  D C Shields; W R Tyor; G E Deibler; E L Hogan; N L Banik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

6.  Proteolysis in quaking mouse brain and spinal cord.

Authors:  W W McAlhaney; N L Banik; S Greenfield; E L Hogan
Journal:  Neurochem Res       Date:  1986-02       Impact factor: 3.996

Review 7.  Mechanism of myelin breakdown in experimental demyelination: a putative role for calpain.

Authors:  K E Schaecher; D C Shields; N L Banik
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

8.  Susceptibility of myelin proteins to a neutral endoproteinase: the degradation of myelin basic protein (MBP) and P2 protein by purified bovine brain multicatalytic proteinase complex (MPC).

Authors:  J Lucas; D Lobo; E Terry; E L Hogan; N L Banik
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

9.  Proteolysis of multiple myelin basic protein isoforms after neurotrauma: characterization by mass spectrometry.

Authors:  Andrew K Ottens; Erin C Golden; Liliana Bustamante; Ronald L Hayes; Nancy D Denslow; Kevin K W Wang
Journal:  J Neurochem       Date:  2007-11-22       Impact factor: 5.372

Review 10.  Developmental and pathophysiological aspects of the myelin-associated glycoprotein.

Authors:  R O Brady; R H Quarles
Journal:  Cell Mol Neurobiol       Date:  1988-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.